Tivic Health Systems, Inc. (TIVC)
NASDAQ: TIVC · IEX Real-Time Price · USD
0.452
+0.045 (11.00%)
At close: Jul 26, 2024, 4:00 PM
0.435
-0.017 (-3.76%)
After-hours: Jul 26, 2024, 7:25 PM EDT
Tivic Health Systems Revenue
Tivic Health Systems had revenue of $334.00K in the quarter ending March 31, 2024, a decrease of -11.17%. This brings the company's revenue in the last twelve months to $1.13M, down -36.58% year-over-year. In the year 2023, Tivic Health Systems had annual revenue of $1.18M, down -36.09%.
Revenue (ttm)
$1.13M
Revenue Growth
-36.58%
P/S Ratio
3.61
Revenue / Employee
$126,000
Employees
9
Market Cap
2.79M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 1.18M | -664.00K | -36.09% |
Dec 31, 2022 | 1.84M | 583.00K | 46.38% |
Dec 31, 2021 | 1.26M | 397.00K | 46.16% |
Dec 31, 2020 | 860.00K | 440.00K | 104.76% |
Dec 31, 2019 | 420.00K | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
cbdMD | 21.58M |
InMed Pharmaceuticals | 5.63M |
Tenon Medical | 3.21M |
Helius Medical Technologies | 668.00K |
60 Degrees Pharmaceuticals | 569.86K |
FOXO Technologies | 139.00K |
TIVC News
- 3 days ago - Tivic Health Expands Intellectual Property Portfolio - Business Wire
- 5 weeks ago - Tivic Health: Christina Valauri Appointed to Board of Directors - Business Wire
- 5 weeks ago - ServiceNow debuts as a Leader in P&C Claims Management Systems report by independent research firm - Business Wire
- 2 months ago - Tivic Health Partners with the Feinstein Institutes to Advance its Patent-pending, Non-Invasive Cervical Vagus Nerve Stimulation; Begins Optimization of ncVNS for use in Clinical Indications - Business Wire
- 2 months ago - Tivic Reports First Quarter 2024 Financial Results and Subsequent Events - Business Wire
- 2 months ago - Tivic Health to Report Q1 2024 Financial Results and Subsequent Events on May 15th Via Conference Call and Webcast - Business Wire
- 2 months ago - Tivic Health Announces Closing of $4.0 Million Public Offering - Business Wire
- 2 months ago - Tivic Health Announces Pricing of $4.0 Million Public Offering - Business Wire